Find clinical trials for Breast Cancer in Detroit, MI
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Breast Cancer trials near Detroit, MI, USA:
The purpose of this study is to test the safety and tolerability of PMD-026 in patients with metastatic breast cancer. PMD-026 is a ...
Phase 1, Phase 2
Farmington Hills, Michigan, United States and 10 other locations
contrast-enhanced spectral mammography (CESM) can detect more cancers with fewer false positives than digital breast tomosynthesis -...
Detroit, Michigan, United States and 10 other locations
to anti-HER2-based therapy plus endocrine therapy alone in improving the outcomes of subjects with hormone receptor-positive, HER2+ metastatic breast...
Phase 3
Ann Arbor, Michigan, United States and 107 other locations
positive (HR+) and human epidermal growth factor 2 negative (HER2-) breast cancer (BC) and other advanced solid tumors. Th...
Phase 1
Detroit, Michigan, United States and 63 other locations
This open-label research study is studying (Z)-endoxifen as a possible treatment for pre-menopausal women with ER+/HER2- breast cancer...
Phase 2
Detroit, Michigan, United States and 14 other locations
in combination with capecitabine in patients with HER2-negative breast cancer with brain metastases. Patients will be enrolled to r...
Phase 2
Farmington Hills, Michigan, United States and 16 other locations
growth factor receptor 2 negative (ER+/HER2-) advanced/metastatic breast cancer. The phase 1b part of the trial will determine the ...
Phase 1, Phase 2
Detroit, Michigan, United States of America and 118 other locations
mg in postmenopausal women with oestrogen receptor positive advanced breast cancer who have failed on a previous endocrine treatmen...
Phase 3
Detroit, Michigan, United States and 105 other locations
in participants with intermediate-risk HR+/HER2- early-stage breast cancer. Based on ctDNA test results, participants will either s...
Detroit, Michigan, United States and 38 other locations
(Part 2). The primary purpose of Dose Expansion (Part 2) is to assess the antitumor activity of BB-1701 at RD in the selected population(s) of breast...
Phase 2
Ann Arbor, Michigan, United States and 48 other locations
Clinical trials
Research sites
Resources
Legal